BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | N205637 | BIODELIVERY SCIENCES INTERNATIONAL INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BioDelivery Sciences International, Inc. et al v. Teva Pharmaceuticals USA, Inc. et al 4 patentsANDA 209831buprenorphine and naloxone | D. Del. | 2017-03-16 | Terminated 2017-10-13 | — |
Indivior Inc. et al v. Biodelivery Sciences International, Inc. et al 5 patentsbuprenorphine/naloxone | NCED | 2015-07-21 | Terminated 2023-03-09 | — |
BioDelivery Sciences International, Inc. v. Reckitt Benckiser Pharmaceuticals, Inc. et al 3 patentsbuprenorphine hydrochloride and naloxone hydrochloride | NCED | 2014-09-20 | Terminated 2021-03-10 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).